f | { | f | { |
| "author": "", | | "author": "", |
| "author_email": "", | | "author_email": "", |
| "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", | | "creator_user_id": "0124c449-4279-4839-a7e2-f7ee873dbc7c", |
| "groups": [ | | "groups": [ |
| { | | { |
| "description": "Group for publications", | | "description": "Group for publications", |
| "display_name": "Publication", | | "display_name": "Publication", |
| "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", | | "id": "816c3c41-f871-427d-9e26-fb21e6b3c578", |
| "image_display_url": | | "image_display_url": |
| mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", | | mw/uploads/group/2022-03-17-123757.433896243660articlesquareicon.png", |
| "name": "publication", | | "name": "publication", |
| "title": "Publication" | | "title": "Publication" |
| } | | } |
| ], | | ], |
| "id": "4bf5409f-4b41-453f-9ff4-e69d37402627", | | "id": "4bf5409f-4b41-453f-9ff4-e69d37402627", |
| "isopen": false, | | "isopen": false, |
| "license_id": "notspecified", | | "license_id": "notspecified", |
| "license_title": "License not specified", | | "license_title": "License not specified", |
| "maintainer": null, | | "maintainer": null, |
| "maintainer_email": null, | | "maintainer_email": null, |
| "metadata_created": "2021-09-16T08:11:54.982901", | | "metadata_created": "2021-09-16T08:11:54.982901", |
n | "metadata_modified": "2022-04-27T09:11:30.756372", | n | "metadata_modified": "2022-04-27T09:12:08.518696", |
| "name": "malawi-integrated-hiv-program-report-2014-q1", | | "name": "malawi-integrated-hiv-program-report-2014-q1", |
| "notes": "This is the 10th quarterly HIV Program report after | | "notes": "This is the 10th quarterly HIV Program report after |
| implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in | | implementation of the 2011 Integrated Clinical\r\nHIV Guidelines in |
| July 2011. A summary of the key achievements between January and March | | July 2011. A summary of the key achievements between January and March |
| 2014\r\nis provided below:\r\n\r\n* Scale-up of integrated HIV | | 2014\r\nis provided below:\r\n\r\n* Scale-up of integrated HIV |
| services had reached the following number of sites:\r\n * __825__ | | services had reached the following number of sites:\r\n * __825__ |
| static (607 within and __218__ outside of health facilities) and 534 | | static (607 within and __218__ outside of health facilities) and 534 |
| outreach HTC sites\r\n\r\n * __694__ (static) ART sites\r\n\r\n | | outreach HTC sites\r\n\r\n * __694__ (static) ART sites\r\n\r\n |
| * __605__ PMTCT sites (Option B+, all included in ART sites | | * __605__ PMTCT sites (Option B+, all included in ART sites |
| above)\r\n\r\n * __651__ Pre-ART sites\r\n\r\n * __627__ sites | | above)\r\n\r\n * __651__ Pre-ART sites\r\n\r\n * __627__ sites |
| with HIV-exposed child follow-up\r\n\r\n* __444,365__ persons were | | with HIV-exposed child follow-up\r\n\r\n* __444,365__ persons were |
| tested and counselled for HIV; __140,942 (32%)__ accessed HTC for | | tested and counselled for HIV; __140,942 (32%)__ accessed HTC for |
| the\r\nfirst time; 303,423 (68%) were repeat testers and 9,112 (3%) of | | the\r\nfirst time; 303,423 (68%) were repeat testers and 9,112 (3%) of |
| these received confirmatory\r\ntesting (after having tested positive | | these received confirmatory\r\ntesting (after having tested positive |
| in the past). This is equivalent to 36% confirmatory\r\ntesting | | in the past). This is equivalent to 36% confirmatory\r\ntesting |
| coverage among 25,363 patients initiating ART this quarter. 32,913 | | coverage among 25,363 patients initiating ART this quarter. 32,913 |
| (7%) out of all\r\nclients received a positive result for the first | | (7%) out of all\r\nclients received a positive result for the first |
| time.\r\n\r\n* __18,850 (93%)__ of __20,242__ blood units collected | | time.\r\n\r\n* __18,850 (93%)__ of __20,242__ blood units collected |
| were screened for (at least) HIV, hepatitis B\r\nand | | were screened for (at least) HIV, hepatitis B\r\nand |
| syphilis.\r\n\r\n* __130,257 (82%)__ of__ 159,233__ women at ANC had | | syphilis.\r\n\r\n* __130,257 (82%)__ of__ 159,233__ women at ANC had |
| their HIV status ascertained; __10,191 (8%)__ of\r\nthese were HIV | | their HIV status ascertained; __10,191 (8%)__ of\r\nthese were HIV |
| positive. __113,169 (93%)__ of __121,579__ women at maternity had | | positive. __113,169 (93%)__ of __121,579__ women at maternity had |
| their HIV status\r\nascertained; __8,822 (8%)__ of these were HIV | | their HIV status\r\nascertained; __8,822 (8%)__ of these were HIV |
| positive.\r\n\r\n* __25,363__ patients started ART this quarter, 8% | | positive.\r\n\r\n* __25,363__ patients started ART this quarter, 8% |
| more than in the previous quarter (23,334).\r\n\r\n* __486,795__ | | more than in the previous quarter (23,334).\r\n\r\n* __486,795__ |
| patients were alive and on ART by end of March 2014. This means that | | patients were alive and on ART by end of March 2014. This means that |
| 49% of the\r\nestimated 1 million HIV positive population was on ART. | | 49% of the\r\nestimated 1 million HIV positive population was on ART. |
| 1 Estimated ART coverage among\r\npeople in need for treatment was | | 1 Estimated ART coverage among\r\npeople in need for treatment was |
| __39% (42,525 / 110,000)__ for children (<15 years) and | | __39% (42,525 / 110,000)__ for children (<15 years) and |
| __78%__\r\n__(444,270 / 570,000)__ for adults.\r\n\r\n* __78%__ of | | __78%__\r\n__(444,270 / 570,000)__ for adults.\r\n\r\n* __78%__ of |
| adults and __78%__ of children were retained alive on ART at 12 months | | adults and __78%__ of children were retained alive on ART at 12 months |
| after initiation.\r\n\r\n* __417,369 (92%)__ of __452,934__ patients | | after initiation.\r\n\r\n* __417,369 (92%)__ of __452,934__ patients |
t | on first line adult ART were on regimen | t | on first line adult ART were on regimen 5A\r\n(TDF/3TC/EFV).\r\n\r\n* |
| 5A\r\n(TDF/3TC/EFV).\r\n\r\n*__10,036 2 (81%)__ of an estimated | | __10,036 2 (81%)__ of an estimated __12,425__ Error! Bookmark not |
| __12,425__ Error! Bookmark not defined. HIV infected pregnant women | | defined. HIV infected pregnant women in\r\nMalawi were on ART this |
| in\r\nMalawi were on ART this quarter. __5,030 (50%)__ of these were | | quarter. __5,030 (50%)__ of these were already on ART when |
| already on ART when getting\r\npregnant and __5,006 (50%)__ started | | getting\r\npregnant and __5,006 (50%)__ started ART during |
| ART during pregnancy/delivery.\r\n\r\n* An additional __1,644__ 2 | | pregnancy/delivery.\r\n\r\n* An additional __1,644__ 2 breastfeeding |
| breastfeeding women started ART due to Option B+ (in WHO | | women started ART due to Option B+ (in WHO stage\r\n1/2)\r\n\r\n* |
| stage\r\n1/2)\r\n\r\n* __77%__, __72%__ and __71%__ of women started | | __77%__, __72%__ and __71%__ of women started under Option B+ were |
| under Option B+ were retained on ART at 6, 12 and\r\n24 months after | | retained on ART at 6, 12 and\r\n24 months after initiation, |
| initiation, respectively.\r\n\r\n* __8,350 (8%)__ of infants | | respectively.\r\n\r\n* __8,350 (8%)__ of infants discharged alive from |
| discharged alive from maternity were known to be HIV exposed, | | maternity were known to be HIV exposed, __7,815\r\n(94%)__ of these |
| __7,815\r\n(94%)__ of these received ARV prophylaxis (nevirapine). | | received ARV prophylaxis (nevirapine). __5,771 (59%)__ were enrolled |
| __5,771 (59%)__ were enrolled in exposed\r\nchild follow-up before age | | in exposed\r\nchild follow-up before age 2 months.\r\n\r\n* A total of |
| 2 months.\r\n\r\n* A total of __10,372__ HIV exposed children and | | __10,372__ HIV exposed children and __8,551__ pre-ART patients were |
| __8,551__ pre-ART patients were enrolled for followup\r\nin HIV Care | | enrolled for followup\r\nin HIV Care Clinics (HCC) during this |
| Clinics (HCC) during this quarter.", | | quarter.", |
| "num_resources": 1, | | "num_resources": 1, |
| "num_tags": 1, | | "num_tags": 1, |
| "organization": { | | "organization": { |
| "approval_status": "approved", | | "approval_status": "approved", |
| "created": "2021-10-14T11:02:35.234558", | | "created": "2021-10-14T11:02:35.234558", |
| "description": "The Department of HIV & AIDS (DHA) was established | | "description": "The Department of HIV & AIDS (DHA) was established |
| in 2001, initially as a unit in the Department of Clinical Services, | | in 2001, initially as a unit in the Department of Clinical Services, |
| to coordinate the biomedical HIV Program in Malawi. The department now | | to coordinate the biomedical HIV Program in Malawi. The department now |
| carries responsibility for various HIV related programs including: | | carries responsibility for various HIV related programs including: |
| sexually transmitted infections (STIs), prevention of mother to child | | sexually transmitted infections (STIs), prevention of mother to child |
| transmission of HIV (PMTCT), and national voluntary male medical | | transmission of HIV (PMTCT), and national voluntary male medical |
| circumcision program (VMMC). All these HIV program sub-sections are | | circumcision program (VMMC). All these HIV program sub-sections are |
| linked to one robust monitoring and evaluation sub-section in the HIV | | linked to one robust monitoring and evaluation sub-section in the HIV |
| and AIDS Department which technically operates under the Central | | and AIDS Department which technically operates under the Central |
| Monitoring and Evaluation Department (CMED) of the Ministry of | | Monitoring and Evaluation Department (CMED) of the Ministry of |
| Health.", | | Health.", |
| "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "id": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "image_url": | | "image_url": |
| 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", | | 2022-04-18-074318.527302WhatsApp-Image-2022-04-18-at-9.42.07-AM.jpeg", |
| "is_organization": true, | | "is_organization": true, |
| "name": "dha", | | "name": "dha", |
| "state": "active", | | "state": "active", |
| "title": "Department of HIV & AIDS and Viral Hepatitis", | | "title": "Department of HIV & AIDS and Viral Hepatitis", |
| "type": "organization" | | "type": "organization" |
| }, | | }, |
| "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", | | "owner_org": "ca6a5fbb-31b1-44f8-9319-5da56d75a55b", |
| "private": false, | | "private": false, |
| "program_area": "Care and Treatment", | | "program_area": "Care and Treatment", |
| "relationships_as_object": [], | | "relationships_as_object": [], |
| "relationships_as_subject": [], | | "relationships_as_subject": [], |
| "resources": [ | | "resources": [ |
| { | | { |
| "cache_last_updated": null, | | "cache_last_updated": null, |
| "cache_url": null, | | "cache_url": null, |
| "created": "2022-03-23T19:55:52.537542", | | "created": "2022-03-23T19:55:52.537542", |
| "description": "", | | "description": "", |
| "format": "PDF", | | "format": "PDF", |
| "hash": "", | | "hash": "", |
| "id": "1155e21f-7887-43c1-a28b-9f9d5ce67fcf", | | "id": "1155e21f-7887-43c1-a28b-9f9d5ce67fcf", |
| "last_modified": "2022-04-05T00:47:55.339425", | | "last_modified": "2022-04-05T00:47:55.339425", |
| "lfs_prefix": | | "lfs_prefix": |
| "dha/malawi-integrated-hiv-program-report-2014-q1", | | "dha/malawi-integrated-hiv-program-report-2014-q1", |
| "metadata_modified": "2022-04-05T00:47:55.349932", | | "metadata_modified": "2022-04-05T00:47:55.349932", |
| "mimetype": "application/pdf", | | "mimetype": "application/pdf", |
| "mimetype_inner": null, | | "mimetype_inner": null, |
| "name": "malawi-integrated-hiv-program-report-2014-q1", | | "name": "malawi-integrated-hiv-program-report-2014-q1", |
| "package_id": "4bf5409f-4b41-453f-9ff4-e69d37402627", | | "package_id": "4bf5409f-4b41-453f-9ff4-e69d37402627", |
| "position": 0, | | "position": 0, |
| "resource_type": null, | | "resource_type": null, |
| "sha256": | | "sha256": |
| "cc1b43553060e44189935310ff014f92629e9c7ce662487df7b0aff45fcaa3ef", | | "cc1b43553060e44189935310ff014f92629e9c7ce662487df7b0aff45fcaa3ef", |
| "size": 1746933, | | "size": 1746933, |
| "state": "active", | | "state": "active", |
| "url": | | "url": |
| 9d5ce67fcf/download/malawi-integrated-hiv-program-report-2014-q1.pdf", | | 9d5ce67fcf/download/malawi-integrated-hiv-program-report-2014-q1.pdf", |
| "url_type": "upload" | | "url_type": "upload" |
| } | | } |
| ], | | ], |
| "state": "active", | | "state": "active", |
| "tags": [ | | "tags": [ |
| { | | { |
| "display_name": "Report", | | "display_name": "Report", |
| "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", | | "id": "37e5a5df-a993-4d3f-8c9c-73c418c30f0f", |
| "name": "Report", | | "name": "Report", |
| "state": "active", | | "state": "active", |
| "vocabulary_id": null | | "vocabulary_id": null |
| } | | } |
| ], | | ], |
| "title": "Malawi Integrated HIV Program Report 2014 Q1", | | "title": "Malawi Integrated HIV Program Report 2014 Q1", |
| "type": "dataset", | | "type": "dataset", |
| "url": null, | | "url": null, |
| "version": null, | | "version": null, |
| "year": "2014" | | "year": "2014" |
| } | | } |